Literature DB >> 19464448

Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium.

Yeong-Hoon Choi1, Douglas B Cowan, Adrian M Moran, Steven D Colan, Christof Stamm, Koh Takeuchi, Ingeborg Friehs, Pedro J del Nido, Francis X McGowan.   

Abstract

OBJECTIVE: Abnormal hemodynamic loading often accompanies congenital heart disease both before and after surgical repair. Adaptive and maladaptive myocardial responses to increased load are numerous. This study examined the hypothesis that myocyte loss occurs during compensatory hypertrophic growth in the developing infant myocardium subjected to progressive pressure overload.
METHODS: Pressure-overload left ventricular hypertrophy was induced in 7- to 10-day-old rabbits by banding the thoracic aorta. Left ventricular function and mechanics were quantified by serial echocardiography and noninvasive left ventricular wall stress analysis. Left ventricular tissue sections were examined for fibrosis by using Masson's trichrome stain and for myocyte apoptosis by using a myocyte-specific DNA fragmentation assay and caspase-3 activation (specific fluorescent substrate).
RESULTS: Significant myocyte apoptosis (198 +/- 37/10(6) myocytes, P < .01 vs control) and caspase-3 activation were present in early hypertrophy when left ventricular contractility was preserved and compensatory hypertrophy had normalized wall stress. By 6 weeks, multiple indices of left ventricular contractility were reduced, and left ventricular wall stress was increased. Myocyte apoptosis was accelerated (361 +/- 56/10(6) myocytes), caspase-3 activity further increased, and the estimated total number of left ventricular myocytes was significantly reduced by 18% +/- 4%.
CONCLUSION: In experimental infant left ventricular hypertrophy, myocyte apoptosis is initiated in the face of normalized wall stress and preserved contractility. The ongoing rate of apoptosis causes a measurable decrease in myocyte number that is coincident with the onset of ventricular dysfunction. It thus appears that pressure overload, even at its earliest stages, is not well tolerated by the developing ventricle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464448      PMCID: PMC2758562          DOI: 10.1016/j.jtcvs.2008.12.020

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  35 in total

Review 1.  Cytoplasmic signaling pathways that regulate cardiac hypertrophy.

Authors:  J D Molkentin; G W Dorn
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

Review 2.  Left ventricular hypertrophy: pathogenesis, detection, and prognosis.

Authors:  B H Lorell; B A Carabello
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

3.  Still stressed out but doing fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure overload.

Authors:  Motoaki Sano; Michael D Schneider
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

4.  Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure.

Authors:  B Ding; R L Price; E C Goldsmith; T K Borg; X Yan; P S Douglas; E O Weinberg; J Bartunek; T Thielen; V V Didenko; B H Lorell
Journal:  Circulation       Date:  2000-06-20       Impact factor: 29.690

5.  Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility.

Authors:  S D Colan; K M Borow; A Neumann
Journal:  J Am Coll Cardiol       Date:  1984-10       Impact factor: 24.094

Review 6.  Genetic dissection of cardiac growth control pathways.

Authors:  W R MacLellan; M D Schneider
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

7.  Wall stress and patterns of hypertrophy in the human left ventricle.

Authors:  W Grossman; D Jones; L P McLaurin
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

8.  Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

Authors:  Giovanni Esposito; Antonio Rapacciuolo; Sathyamangla V Naga Prasad; Hideyuki Takaoka; Steven A Thomas; Walter J Koch; Howard A Rockman
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

9.  Functional consequences of caspase activation in cardiac myocytes.

Authors:  Catherine Communal; Marius Sumandea; Pieter de Tombe; Jagat Narula; R John Solaro; Roger J Hajjar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

10.  Use of the indirect axillary pulse tracing for noninvasive determination of ejection time, upstroke time, and left ventricular wall stress throughout ejection in infants and young children.

Authors:  S D Colan; K M Borow; D MacPherson; S P Sanders
Journal:  Am J Cardiol       Date:  1984-04-01       Impact factor: 2.778

View more
  7 in total

Review 1.  Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.

Authors:  Ljuba Bacharova; Martin Ugander
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

2.  Apoptosis in severe, compensated pressure overload predominates in nonmyocytes and is related to the hypertrophy but not function.

Authors:  Ricardo J Gelpi; Misun Park; Shumin Gao; Sunil Dhar; Dorothy E Vatner; Stephen F Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

3.  Hemodynamic stability during biventricular pacing after cardiopulmonary bypass.

Authors:  Mathew E Spotnitz; Daniel Y Wang; T Alexander Quinn; Marc E Richmond; Alexander Rusanov; Taylor Johnston; Bin Cheng; Santos E Cabreriza; Henry M Spotnitz
Journal:  J Cardiothorac Vasc Anesth       Date:  2011-04       Impact factor: 2.628

4.  Electron transport chain dysfunction in neonatal pressure-overload hypertrophy precedes cardiomyocyte apoptosis independent of oxidative stress.

Authors:  Eric R Griffiths; Ingeborg Friehs; Elisabeth Scherr; Dimitrios Poutias; Francis X McGowan; Pedro J Del Nido
Journal:  J Thorac Cardiovasc Surg       Date:  2009-12-28       Impact factor: 5.209

5.  Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.

Authors:  Yong Ye; Hui Gong; Xingxu Wang; Jian Wu; Shijun Wang; Jie Yuan; Peipei Yin; Guoliang Jiang; Yang Li; Zhiwen Ding; Weijing Zhang; Jingmin Zhou; Junbo Ge; Yunzeng Zou
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

6.  Computational analysis of the hemodynamic characteristics under interaction influence of β-blocker and LVAD.

Authors:  Kaiyun Gu; Zhe Zhang; Yu Chang; Bin Gao; Feng Wan
Journal:  Biomed Eng Online       Date:  2018-12-03       Impact factor: 2.819

7.  Association of Endonuclease G Gene Variants with Cardiovascular Disease Risk Factors.

Authors:  Negar Etehad Roodi; Nushin Karkuki Osguei; Mahdy Hasanzadeh Daloee; Alireza Pasdar; Majid Ghayour-Mobarhan; Gordon Ferns; Ali Samadi Kuchaksaraei
Journal:  Rep Biochem Mol Biol       Date:  2019-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.